Key facts
- This page summarizes John E. Imhoff's Form 4 filing for GUIDED THERAPEUTICS INC (GTHP).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Dec 2024, 18:29.
John E. Imhoff - 18 Dec 2024 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- GTHP
- Reported as of
- 18 Dec 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Dec 2024, 18:29:20 UTC
- Prior SEC filing
- 25 Oct 2024
- Next SEC filing
- 18 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John E. Imhoff
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Imhoff filed Form 4 for GUIDED THERAPEUTICS INC (GTHP) on 20 Dec 2024.
Change
- Previous filing in this sequence was filed on 25 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GTHP
transaction
Common Stock
Purchase
- Transaction value
- Shares
- +1,615,385
- Change %
- +23%
- Price
- Shares after
- 8,727,444
- Date
- 18 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GTHP
transaction
Derivative
Warrants
Purchase
- Transaction value
- Shares
- +1,615,385
- Change %
- Price
- Shares after
- 1,615,385
- Date
- 18 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,615,385
- Exercise price
- $0.1800
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On December 18, 2024, the Company entered into a Securities Purchase Agreement with Mr. Imhoff pursuant to which, for an aggregate purchase price of $210,000, the Company issued 1,615,385 shares of its common stock and warrants to purchase an aggregate of 1,615,385 shares of common stock. The warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.18 per share.